West Nile Encephalitis in 2 Hematopoietic Stem Cell Transplant Recipients: Case Series and Literature Review
Author(s) -
David S. Hong,
Kalen Jacobson,
Issam Raad,
Marcos de Lima,
Paolo Anderlini,
Gregory N. Fuller,
Cindy Ippoliti,
Rita Cool,
Norman E. Leeds,
A. Narvios,
Xiang-Yang Han,
Anthony Padula,
R. Champlin,
Chitra Hosing
Publication year - 2003
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/378278
Subject(s) - west nile virus , medicine , hematopoietic stem cell transplantation , immunosuppression , transplantation , virus , virology , encephalitis , immunology , disease , viral disease
Most human cases of West Nile virus infection are acquired via bites from an infected mosquito. In some cases, infection may also be transmitted by infected blood products or transplanted organs. There have been recent publications suggesting that chemotherapy and immunosuppression may increase a person's risks of developing central nervous system disease if the person is infected with the West Nile virus. Because patients undergoing hematopoietic stem cell transplantation not only are immunocompromised, but also receive multiple blood products, they are at a particularly high risk for acquiring symptomatic disease if exposed to the West Nile Virus. We describe here 2 patients who underwent hematopoietic transplantation at our institution and subsequently developed fatal West Nile virus infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom